ProCE Banner Activity

Advances in the Management of Metastatic Castration-Resistant Prostate Cancer: Expert Guidance and Resources for the Interdisciplinary Team

Slideset

Expert authored downloadable slideset covering current guidelines for the optimal management of metastatic castration-resistant prostate cancer.

Released: October 25, 2023

Share

Faculty

Alan H. Bryce

Alan H. Bryce, MD

Chief Clinical Officer
Professor, Department of Medical Oncology and Therapeutics Research 
Professor of Molecular Medicine, TGEN
City of Hope
Phoenix, Arizona

Rana R. McKay

Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

Provided by

Provided by the National Comprehensive Cancer Network (NCCN) in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Clinical Care Options, LLC

ProCE Banner